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Bias and Unicompartmental Knee Replacement 
DW Murray, A Liddle, A Judge, H Pandit 
Abstract 
We recently published a paper comparing the incidence of adverse outcomes after 
Unicompartmental and Total Knee replacement (UKR & TKR).  The conclusion of this 
study, which was in favour of UKR, was dismissed as biased in a review in Bone & Joint 360 
1 that was subsequently reprinted in the Bone and Joint Journal 2.  Although this study is one 
of the least biased comparisons of UKR and TKR, this episode highlights the biases that exist 
both towards and against UKR.  In this review we give examples of different sources of bias 
and how they can be avoided based on our published paper, National Registry data and a 
meta-analysis of published data.  Our conclusion is that comparisons between UKR and TKR 
are open to bias.  These biases are so marked in comparisons made by National Registers 
based on revision rate that the conclusions are misleading.  For a fair comparison data from 
randomised studies or well matched prospective observational cohort studies, which may be 
based on registry data, are required and multiple outcome measures should be used. The data 
of this type that already exists is in favour of UKR. 
Adverse Outcomes Study 
The study comparing the incidence of adverse outcomes after UKR and TKR was a matched 
study based on data from the NJR (National Joint Registry for England and Wales) and other 
large datasets 3.  The incidence of all adverse outcomes except reoperation and revision were 
lower after UKR.  To put this in perspective we stated “If 100 patients receiving TKR 
received UKR instead; the result would be around one less death and three more reoperations 
in the first four years after surgery”.  The Bone & Joint 360 review, with which no author was 
associated, dismissed this as “Bias in reporting? Quite possibly” 1.  It also suggested that we 
should have made the comparison at an earlier time point, missing the point of paper which 
was a comparison of adverse outcomes not just immediately post-operatively but also out to 
eight years.  In fact, we chose the time point arguably least favourable to UKR.  At an earlier 
time point, for example at one year, both the death rate and the re-operation were less for 
UKR than for TKR.  We did not quote the comparison at eight years as the numbers of 
patients with this length of follow-up was low, but if we had, the message would have been 
starker: “If 60 patients receiving TKR received UKR instead, the result would be around one 
less death and three more reoperations in the first 8 years after surgery”.  
Perhaps the bias is not in the presentation, but in the data and the analysis.  The data is, 
however, freely available, standard and appropriate statistical techniques were used and we 
followed the STROBE guidelines for reporting of observational studies 4.  As it was not 
possible to answer our research question using a randomised controlled trial (RCT, such as 
TOPKAT 5), due to the rarity of adverse events such as mortality, we used the next best study 
design which is a prospective observational cohort study.  The most important potential bias 
in this study and most comparative studies is selection bias as TKR and UKR tend to be 
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implanted in different patients. To avoid this bias we matched patients with propensity score 
analysis 6, which provides balanced baseline characteristics in both groups. As every patient 
that had a UKR would have had a TKR had they been treated by a non-UKR surgeon 
virtually all UKR patients were matched with TKR controls. In addition all patients receiving 
TKR with no comparable UKR controls were eliminated.  There is not enough data within the 
NJR for adequate matching so we used data from multiple sources.  Despite matching on over 
20 variables the groups may still have been inadequately matched.  However as discussed in 
our paper this is unlikely to have affected the conclusions. Furthermore another paper from 
the NJR based on the same data and presented by a group with no known bias in favour of 
UKR came to the same conclusion as we did about the short term mortality rate 7. 
National Registers 
Due to the way National Registers are set up, and through no fault of the individuals 
involved, they are inherently biased against UKR.  In every National Register the failure rate 
of UKR is about three times higher than that of TKR, so it is recommended that UKR should 
not be widely used 8,9.  This conclusion is not justified because of the selection, reporting and 
measurement bias inherent in the Registers.  The selection bias occurs because UKR tend to 
be implanted in younger and fitter patients than TKR and younger and fitter patients have 
higher revision rates. Joint registers do not collect enough data to adequately match patients: 
The difference in the revision rate between UKR and TKR is twice as high in NJR data as it 
is in a matched comparison using NJR and other data sets 3.  The reporting bias occurs 
because Registers focus on only one outcome measure: Revision.  UKR do worse than TKR 
with revision as the outcome measure but with virtually all other outcomes measures UKR do 
better 3,10,11.  From a Registers point of view if a joint replacement is revised it is considered 
to have failed, whereas if it is not revised it is considered to be a success.  Therefore it is 
considered to be a success even if the patient has worse symptoms post-op than pre-op and it 
is considered a failure if a patient has an excellent outcome but required minor surgery such 
as a wash out and bearing change.  Furthermore it is considered a success if the patient dies 
or has a major medical complication as a result of the surgery, and in some registers a TKR is 
considered a success even if it has ended as a fusion or amputation. 
The main bias in National Registries, which cannot be avoided, is measurement bias.  There 
is measurement bias because the decision to revise depends on many factors 12 some of which 
may be influenced by the type of joint replacement.  For example, as UKR is easier to revise 
than TKR the threshold for revision is lower 13.  Therefore a UKR with a poor outcome will 
be more likely to be revised than a TKR with a similarly poor outcome.  There is good 
evidence from the New Zealand Joint Registry (NZJR) that this is one of the main reasons 
why UKR have a higher revision rate than UKR 13.  The NZJR, as well as collecting data 
about revision, collects Oxford Knee Scores (OKS) at six months after the operation and 
categorises the score into poor, fair, good and excellent 10,14.  This demonstrates that UKR 
have 30% more excellent results, whereas TKR have 60% more poor results.  (Findings 
supported by data from other studies 10).  Therefore the higher revision rate is not because 
UKR have more poor results, as they actually have less.  The NZJR also compares the six 
month OKS with the subsequent revision rate.  Whatever the outcome score, the revision rate 
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of UKR is about five times higher than that of TKR 10,13.  Therefore factors independent of 
outcome score, such as the threshold for revision, increase the revision rate fivefold.  The 
most striking difference in revision rate occurs in patients who have a worse score 
postoperatively than preoperatively (largely those with a postoperative OKS less than 20).  
These patients have a 10% chance of being revised if they have had a TKR and a 60% chance 
of being revised if they have had a UKR.  Most surgeons would agree that it is an advantage 
of UKR over a TKR that it is relatively straightforward to revise if there is a problem.  The 
consequence of it being easier to revise is that the threshold for revision is lower.  As a result 
the revision rate is higher even though the chance of getting a poor result is lower.  Therefore 
a comparison of UKR with TKR based purely on revision rates is misleading as it suggests 
that UKR have worse outcomes than TKR when the data suggest that they have better 
outcomes.  
The NJR has recently stated that comparisons between UKR and TKR should not be based on 
Revision rate alone.  Thus the NJR is acknowledging that it is acceptable for the revision rate 
for UKR to be higher than TKR provided that there are other advantages of UKR.  It is 
therefore biased that the identification of surgeon outliers is based solely on revision rate and 
it is assumed the revision rate of UKR and TKR should be the same.  The primary method 
used to identify an outlier is the funnel plot of all knee replacements based on the combined 
revision rate of UKR and TKR.  As the revision rate of UKR is higher than TKR surgeons 
who do UKR are likely appear worse on the funnel plot than those that do not.  Furthermore 
surgeons who do UKR are more likely to be outliers and outliers are more likely to be 
surgeons who do UKR.  We are aware of a number of surgeons who are outliers for all 
replacements combined, yet are average for both UKR and TKR when these are analysed 
separately.  These surgeons are being put under pressure to stop being outliers, and the only 
way they can rapidly do this is to stop doing UKR.  There is a simple solution to this bias 
against UKR:  When the analysis is undertaken for the combined funnel plot, adjustments 
should be made based on the average revision rate of UKR and TKR 15.  Following these 
adjustments surgeons that have average performance for both UKR and TKR separately 
would have average performance on the combined funnel plot and would not be outliers.  The 
outlier system would then identify surgeons with bad results, whether they use UKR or TKR.  
It would encourage these surgeons to improve their results by focusing on their indications, 
techniques and implant design rather than encouraging surgeons to stop doing UKR.  
Meta-analysis 
A meta-analysis of the results of the Oxford UKR published in 2011 illustrates other biases 
and misunderstanding associated UKR 16.  In this meta-analysis, compared to the designer 
surgeons, the revision rate was four times higher in registry data and three times higher in 
independent series.  The authors state that “the cause of this divergence can only be an issue 
for speculation”.  However it is clear from the lead author’s presentations that he considers 
that the designer’s data is not only biased but also unbelievable. The designer’s data in the 
NJR is also substantially better than average demonstrating that the designer’s publications 
are not fraudulent and probably not biased.  We find it surprising that authors did not 
consider the explanation of their findings to be obvious.  The results of knee replacement 
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depend not only on the implant but also on the indications and surgical technique.  It is for 
this reason that there are such large discrepancies between the results of the same implant in 
different registries (For example the Repicci UKR was the best performing UKR in Australia 
17 and the worst in Sweden 18 in 2005).  Clearly the designer surgeons are likely to use the 
appropriate indications and surgical techniques so their results are likely to be indicative of 
the best results that can be achieved by a particular implant. In the NJR surgeons do on 
average 5 UKR per year so in this Register, and presumably in other registers, poor results 
would be expected. The authors 16 also state that other surgeons “cannot expect to reproduce 
(the) excellent results” achieved by the designers surgeon.  This is incorrect.  For example 
Keys’ results, published in 2004 19, were actually better than those of the designers, although, 
for some reason, these results were not included in the meta-analysis.  Furthermore, since the 
meta-analysis, we have become aware of nine series that have been presented or published, 
which quote the 10 year survival of the Phase 3 Oxford UKR 20. The survival from the 
designer surgeons 21 and the independent surgeons is similar.  It would therefore seem that if 
surgeons adhere to the recommended indications and techniques then they can expect to 
reproduce the results of the designer surgeons.  The indications for the Oxford UKR are 
clearly defined and are satisfied in about 50% of the cases requiring knee replacement 22.  In 
the nine series the surgeons tended to use the Oxford UKR in 20% to 60% of their knee 
replacements. Analysis of NJR data has shown that the best results are achieved with the 
Oxford UKR when surgeons use it in between 20% and 60% of their knee replacements 23.  
NJR data shows that most surgeons who use the Oxford UKR do it in less than 10% of their 
knee replacements, which suggests that most surgeons are not using the recommended 
indications.  The solution seems simple:  If surgeons want to use the Oxford UKR they 
should adhere to the recommended indications. They would then be doing UKR on all 
appropriate patients and would be doing enough to have the necessary experience to get good 
results.  
Conclusion 
In conclusion comparisons between UKR and TKR are open to bias.  This is particularly 
marked in comparisons made by National Registers based on revision rate.  In these 
circumstances the selection, reporting and measurement bias are so great that the conclusions 
are misleading.  As a result it is not appropriate to use these analyses to compare UKR and 
TKR and furthermore when identifying surgeon outliers it is not appropriate to assume the 
revision rate of UKR and TKR should be the same.  For a fair comparison of UKR and TKR 
data from RCT or well matched prospective observational cohort studies is required and 
multiple outcome measures should be used, including adverse events, patient reported 
outcome measures (PROMs) and cost-effectiveness.  Very little data of this type exists and 
the data that does exist is in favour of UKR 3,10,11,24,25.  This therefore supports the increased 
use of UKR.  There is also good evidence to suggest that if surgeons want to do UKR they 
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